Determines early market access potential, pricing and strategy for pipeline indications and assets including indication sequencing, TPP, and TPL
Work with Indication Development Teams (IDTs) to optimize trial designs so they reflect payer requirements
Coordinate Early Scientific Advice from key HTA Agencies and conduct gap analyses with external consultants
Work with Indication Commercial Teams (ICTs) to align Access and Commercial positioning, pricing and strategy
Assess unmet need, outline payer value proposition, assess P&R / HTA landscape and product outlook
Inform development of global pricing strategy and policy
Test payer value messages, pricing expectations, and value proposition via Advisory Boards and research with payers / HTA
Develop core value dossier and objection handler
Develop innovative access strategies on a global and regional level including early access, and evaluate implications for launch (go, no-go risk mitigation and scenario planning)
Build out and validate contracting options and G2N assumptions
Partner with HEOR and Regional Access to optimize the evidence generation plan, identify epidemiology and the unmet medical need
Inform the development of health economic and outcomes analyses (CEA, BIA, burden of disease, etc.) required for access
Facilitate launch readiness workshops with regional and local Market Access and other functions
Requirements
7+ years of relevant industry experience in biotech/pharma
5+ years Market Access & Pricing experience specifically involving specialty drug launches in US or Europe
Advanced graduate level training in the natural sciences, medicine, business, engineering, or finance required
Master’s degree in Business Administration, Health Economics, Life Sciences, or a related field
Ph.D. or MBA preferred
Strong leadership and team management skills, with the ability to influence and align cross-functional teams
Strategic and critical thinking and problem-solving skills
Regular Travel Required
Fluent English language required
Based in Belgium or Switzerland or US (East Coast) or willing to relocate
Experience and deep understanding of payer needs, decision-making approaches, strategies, and country reimbursement stakeholders and influencers in US and/or key EU markets
Experience working with clinical development teams
Experience working within launch and commercialization teams for therapies in the orphan and rare disease space